Bard Associates’s Nephros NEPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $536K | Sell |
131,121
-12,100
| -8% | -$49.5K | 0.17% | 114 |
|
|
2025
Q1 | $246K | Sell |
143,221
-12,050
| -8% | -$20.7K | 0.09% | 145 |
|
|
2024
Q4 | $228K | Sell |
155,271
-17,100
| -10% | -$25.1K | 0.08% | 151 |
|
|
2024
Q3 | $295K | Sell |
172,371
-3,225
| -2% | -$5.52K | 0.1% | 149 |
|
|
2024
Q2 | $371K | Sell |
175,596
-3,780
| -2% | -$7.98K | 0.14% | 131 |
|
|
2024
Q1 | $393K | Sell |
179,376
-7,942
| -4% | -$17.4K | 0.14% | 130 |
|
|
2023
Q4 | $648K | Buy |
187,318
+1,279
| +0.7% | +$4.43K | 0.25% | 111 |
|
|
2023
Q3 | $275K | Sell |
186,039
-6,900
| -4% | -$10.2K | 0.11% | 144 |
|
|
2023
Q2 | $299K | Sell |
192,939
-1,350
| -0.7% | -$2.09K | 0.12% | 140 |
|
|
2023
Q1 | $208K | Sell |
194,289
-500
| -0.3% | -$535 | 0.09% | 161 |
|
|
2022
Q4 | $225K | Sell |
194,789
-57,335
| -23% | -$66.3K | 0.1% | 154 |
|
|
2022
Q3 | $229K | Sell |
252,124
-11,630
| -4% | -$10.6K | 0.1% | 148 |
|
|
2022
Q2 | $404K | Buy |
263,754
+17,346
| +7% | +$26.6K | 0.17% | 121 |
|
|
2022
Q1 | $1.08M | Buy |
246,408
+13,900
| +6% | +$61.1K | 0.38% | 90 |
|
|
2021
Q4 | $1.37M | Sell |
232,508
-1,700
| -0.7% | -$10K | 0.45% | 83 |
|
|
2021
Q3 | $2.05M | Buy |
234,208
+2,700
| +1% | +$23.7K | 0.69% | 57 |
|
|
2021
Q2 | $2.35M | Buy |
231,508
+12,130
| +6% | +$123K | 0.77% | 53 |
|
|
2021
Q1 | $1.46M | Buy |
219,378
+12,530
| +6% | +$83.3K | 0.53% | 74 |
|
|
2020
Q4 | $1.78M | Buy |
206,848
+5,050
| +3% | +$43.3K | 0.7% | 50 |
|
|
2020
Q3 | $1.46M | Sell |
201,798
-671
| -0.3% | -$4.85K | 0.77% | 48 |
|
|
2020
Q2 | $1.7M | Sell |
202,469
-5,100
| -2% | -$42.8K | 0.94% | 40 |
|
|
2020
Q1 | $2.64M | Buy |
+207,569
| New | +$2.64M | 1.94% | 9 |
|